Drawing for NOVORIG

USPTO serial 90977298

NOVORIG

Reviewed by CopyMark Law Group

Reg. 6863141Status 700Registered
Filing date
Status date
Registration date
Oct 4, 2022
Examiner
CUMMINS, LANCE E
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with NOVORIG?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Jeffrey B. Sladkus, Esq.

Jeffrey B. Sladkus, Esq. The Sladkus Law Group1397 Carroll DriveAtlanta, GA 30318UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
042Development of new technology for others in the field of biotechnology; Proteomics analysis services for scientific research purposes; Antibody profiling for scientific research purposes; Laboratory research in the field of immune sequencing; Medical and scientific research in the field of cancer treatment and diagnosis; Medical and scientific research in the field of immune sequencing; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals; Medical research and medical research analysis in the field of medicine; Research and development in the pharmaceutical and biotechnology fields; Research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; Medical laboratory servicesACTIVEMay 28, 2020

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 4, 2022NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Oct 4, 2022R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 19, 2022NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jul 19, 2022PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 29, 2022NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jun 16, 2022CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 16, 2022TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 16, 2022CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 15, 2022ALIEASSIGNED TO LIE—
Jun 13, 2022ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Jun 2, 2022AAUANOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED—
Jun 1, 2022GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Jun 1, 2022GNSLLETTER OF SUSPENSION E-MAILED—
Jun 1, 2022CNSLSUSPENSION LETTER WRITTEN—
Jun 1, 2022IUAAUSE AMENDMENT ACCEPTED—
May 31, 2022DPCCDIVISIONAL PROCESSING COMPLETE—
May 31, 2022AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
May 3, 2022AUPCAMENDMENT TO USE PROCESSING COMPLETE—
May 3, 2022IUAFUSE AMENDMENT FILED—
May 3, 2022DRRRDIVISIONAL REQUEST RECEIVED—
May 3, 2022ERTDTEAS REQUEST TO DIVIDE RECEIVED—
May 3, 2022EAAUTEAS AMENDMENT OF USE RECEIVED—
May 3, 2022ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Nov 5, 2021GNS2NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED—
Nov 5, 2021GNSIINQUIRY TO SUSPENSION E-MAILED—
Nov 5, 2021CNSISUSPENSION INQUIRY WRITTEN—
May 5, 2021GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
May 5, 2021GNSLLETTER OF SUSPENSION E-MAILED—
May 5, 2021CNSLSUSPENSION LETTER WRITTEN—
Apr 12, 2021DOCKASSIGNED TO EXAMINER—
Mar 23, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 23, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 18, 2021ALIEASSIGNED TO LIE—
Dec 16, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 14, 2020CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Dec 14, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Dec 14, 2020ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Dec 14, 2020ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 14, 2020REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Dec 14, 2020COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Dec 8, 2020GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 8, 2020GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 8, 2020CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 8, 2020DOCKASSIGNED TO EXAMINER—
Sep 17, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—

Frequently asked questions

Related guidance